Literature DB >> 26648537

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

M Gentile1, T D Shanafelt2, G Cutrona3, S Molica4, G Tripepi5, I Alvarez6, F R Mauro7, N Di Renzo8, F Di Raimondo9, I Vincelli10, K Todoerti11, S Matis12, C Musolino13, S Fabris14, E Vigna1, L Levato4, S Zupo3, F Angrilli15, U Consoli16, G Festini17, G Longo18, A Cortelezzi14, A Arcari19, M Federico20, D Mannina21, A G Recchia22, A Neri14, N E Kay2, M Ferrarini12, F Morabito1,22.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26648537     DOI： 10.1038/leu.2015.333

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.

Authors:  Fortunato Morabito; Giovanna Cutrona; Massimo Gentile; Serena Matis; Katia Todoerti; Monica Colombo; Claudia Sonaglio; Sonia Fabris; Daniele Reverberi; Mauro Megna; Mauro Spriano; Eugenio Lucia; Edoardo Rossi; Vincenzo Callea; Carla Mazzone; Gianluca Festini; Simonetta Zupo; Stefano Molica; Antonino Neri; Manlio Ferrarini
Journal:  Br J Haematol       Date:  2009-05-06       Impact factor: 6.998

2.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

3.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Authors:  Massimo Gentile; Giovanna Cutrona; Laura Mosca; Serena Matis; Sonia Fabris; Marta Lionetti; Fiorella Ilariucci; Simona Zupo; Caterina Musolino; Luciano Levato; Stefano Molica; Francesco Di Raimondo; Iolanda Vincelli; Nicola Di Rienzo; Emanuela Anna Pesce; Francesco Angrilli; Massimo Federico; Antonino Neri; Manlio Ferrarini; Fortunato Morabito
Journal:  Am J Hematol       Date:  2014-04-18       Impact factor: 10.047

5.  Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

Authors:  Natali Pflug; Jasmin Bahlo; Tait D Shanafelt; Barbara F Eichhorst; Manuela A Bergmann; Thomas Elter; Kathrin Bauer; Gebhart Malchau; Kari G Rabe; Stephan Stilgenbauer; Hartmut Döhner; Ulrich Jäger; Michael J Eckart; Georg Hopfinger; Raymonde Busch; Anna-Maria Fink; Clemens-Martin Wendtner; Kirsten Fischer; Neil E Kay; Michael Hallek
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

6.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.

Authors:  William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Hagop Kantarjian; Michael Keating
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

9.  CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Authors:  Tait D Shanafelt; Susan M Geyer; Nancy D Bone; Renee C Tschumper; Tom E Witzig; Greg S Nowakowski; Clive S Zent; Tim G Call; Betsy Laplant; Gordon W Dewald; Diane F Jelinek; Neil E Kay
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

10.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113
View more
  8 in total

1.  The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Authors:  Stefano Molica; Tait D Shanafelt; Diana Giannarelli; Massimo Gentile; Rosanna Mirabelli; Giovanna Cutrona; Luciano Levato; Nicola Di Renzo; Francesco Di Raimondo; Caterina Musolino; Francesco Angrilli; Angelo Famà; Anna Grazia Recchia; Kari G Chaffee; Antonino Neri; Neil E Kay; Manlio Ferrarini; Fortunato Morabito
Journal:  Am J Hematol       Date:  2016-08-08       Impact factor: 10.047

2.  The Predominant Prognostic Significance of NOTCH1 Mutation Defined by Emulsion PCR in Chronic Lymphocytic Leukemia.

Authors:  Katarzyna Skórka; Michał Chojnacki; Marta Masternak; Agnieszka Karczmarczyk; Edyta Subocz; Ewa Wawrzyniak; Krzysztof Giannopoulos
Journal:  Cancer Manag Res       Date:  2021-05-06       Impact factor: 3.989

3.  The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.

Authors:  Sameer A Parikh; Kari G Rabe; Neil E Kay; Timothy G Call; Wei Ding; Jose F Leis; Saad S Kenderian; Eli Muchtar; Yucai Wang; Amber B Koehler; Susan M Schwager; Connie E Lesnick; Geffen Kleinstern; Daniel Van Dyke; Curtis A Hanson; Esteban Braggio; Susan L Slager; Tait D Shanafelt
Journal:  Blood       Date:  2021-07-15       Impact factor: 25.476

Review 4.  Long non-coding RNAs in B-cell malignancies: a comprehensive overview.

Authors:  Lucia Nobili; Domenica Ronchetti; Elisa Taiana; Antonino Neri
Journal:  Oncotarget       Date:  2017-04-20

5.  Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.

Authors:  Caroline Holm Nørgaard; Lasse Hjort Jakobsen; Andrew J Gentles; Karen Dybkær; Tarec Christoffer El-Galaly; Julie Støve Bødker; Alexander Schmitz; Preben Johansen; Tobias Herold; Karsten Spiekermann; Jennifer R Brown; Josephine L Klitgaard; Hans Erik Johnsen; Martin Bøgsted
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.752

6.  Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.

Authors:  Juliana Ochoa-Grullón; Kissy Guevara-Hoyer; Cristina Pérez López; Rebeca Pérez de Diego; Ascensión Peña Cortijo; Marta Polo; Marta Mateo Morales; Eduardo Anguita Mandley; Carlos Jiménez García; Estefanía Bolaños; Belén Íñigo; Fiorella Medina; Antonia Rodríguez de la Peña; Carmen Izquierdo Delgado; Eduardo de la Fuente Muñoz; Elsa Mayol; Miguel Fernández-Arquero; Ataúlfo González-Fernández; Celina Benavente Cuesta; Silvia Sánchez-Ramón
Journal:  Biomedicines       Date:  2022-08-19

7.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31

8.  lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.

Authors:  D Ronchetti; M Manzoni; L Agnelli; C Vinci; S Fabris; G Cutrona; S Matis; M Colombo; S Galletti; E Taiana; A G Recchia; S Bossio; M Gentile; C Musolino; F Di Raimondo; A Grilli; S Bicciato; A Cortelezzi; P Tassone; F Morabito; M Ferrarini; A Neri
Journal:  Blood Cancer J       Date:  2016-09-09       Impact factor: 11.037
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.